IC
PFE icon

IKOS CIF’s Pfizer PFE Stock Holding History

IKOS CIF’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,240
Closed -$75K – 199
2016
Q2 		$75K Sell
2,240
-26,326
-92% -$840K 0.26% 76
2016
Q1 		$804K Buy
28,566
+13,387
+88% +$382K 1.96% 2
2015
Q4 		$470K Buy
15,179
+5,166
+52% +$163K 1.44% 5
2015
Q3 		$293K Buy
10,013
+2,635
+36% +$84.5K 0.85% 23
2015
Q2 		$236K Buy
+7,378
New +$240K 0.78% 41
2014
Q4 		– Sell
-25,970
Closed -$739K – 302
2014
Q3 		$739K Buy
25,970
+25,938
+81,056% +$728K 1.06% 3
2014
Q2 		$1K Buy
+32
New +$912 ﹤0.01% 191
2014
Q1 		– Sell
-3,407
Closed -$99K – 281
2013
Q4 		$99K Buy
+3,407
New +$99.2K 0.25% 108
2013
Q3 		– Sell
-16,934
Closed -$452K – 244
2013
Q2 		$452K Buy
+16,934
New +$468K 0.84% 38

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IKOS CIF's PFE Position: Q3 2016 in Review

IKOS CIF sold out of Pfizer (PFE) in Q3 2016, closing a stake of 2,240 shares — an estimated $75K sold.

IKOS CIF first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $804K in Q1 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • IKOS CIF reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • IKOS CIF sold 2,240 Pfizer shares in Q3 2016, an estimated $75K.
  • IKOS CIF first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
  • IKOS CIF's Pfizer position peaked at $804K in Q1 2016.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on IKOS CIF's 13F filing for Q3 2016, filed 10 Nov 2016.